Clinical Trial: DURING CHEST SURGERY, ONE LUNG IS ISOLATED FROM VENTILATION TO IMPROVE VISIBILITY, WITH CARBON DIOXIDE INTRODUCED BETWEEN THE LUNG AND CHEST WALL (CAPNOTHORAX): THE STUDY SEEKS TO OPTIMIZE VENTILATION THROUGH ESOPHAGEAL PRESSURE MEASUREMENT, REDUCING RESPIRATORY COMPLICATIONS

U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06837636) titled 'DURING CHEST SURGERY, ONE LUNG IS ISOLATED FROM VENTILATION TO IMPROVE VISIBILITY, WITH CARBON DIOXIDE INTRODUCED BETWEEN THE LUNG AND CHEST WALL (CAPNOTHORAX): THE STUDY SEEKS TO OPTIMIZE VENTILATION THROUGH ESOPHAGEAL PRESSURE MEASUREMENT, REDUCING RESPIRATORY COMPLICATIONS' on Feb. 15.

Brief Summary: THE OBJECTIVE OF THIS SINGLE-CENTER OBSERVATIONAL STUDY IS TO IMPROVE THE SAFETY AND EFFECTIVENESS OF CHEST SURGERY THROUGH THE USE OF A NEW VENTILATION TECHNIQUE. DURING THE OPERATION, TO ALLOW THE SURGEON TO WORK MORE PRECISELY, ONLY ONE LUNG WILL RECEIVE AIR FROM THE RESPIRATOR. TO IMPROVE VISIBILITY DURING SURGERY, A SMALL AMOUNT...